{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T04:00:26Z","timestamp":1794369626909,"version":"4.9.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T00:00:00Z","timestamp":1687910400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T00:00:00Z","timestamp":1687910400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    A functional, multi-organ, serum-free system was developed for the culture of\n                    <jats:italic>P. falciparum<\/jats:italic>\n                    in an attempt to establish innovative platforms for therapeutic drug development. It contains 4 human organ constructs including hepatocytes, splenocytes, endothelial cells, as well as recirculating red blood cells which allow for infection with the parasite. Two strains of\n                    <jats:italic>P. falciparum<\/jats:italic>\n                    were used: the 3D7 strain, which is sensitive to chloroquine; and the W2 strain, which is resistant to chloroquine. The maintenance of functional cells was successfully demonstrated both in healthy and diseased conditions for 7\u00a0days in the recirculating microfluidic model. To demonstrate an effective platform for therapeutic development, systems infected with the 3D7 strain were treated with chloroquine which significantly decreased parasitemia, with recrudescence observed after 5\u00a0days. Conversely, when the W2 systems were dosed with chloroquine, parasitemia levels were moderately decreased when compared to the 3D7 model. The system also allows for the concurrent evaluation of off-target toxicity for the anti-malarial treatment in a dose dependent manner which indicates this model could be utilized for therapeutic index determination. The work described here establishes a new approach to the evaluation of anti-malarial therapeutics in a realistic human model with recirculating blood cells for 7\u00a0days.\n                  <\/jats:p>","DOI":"10.1038\/s41598-023-35694-4","type":"journal-article","created":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T15:02:16Z","timestamp":1687964536000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Development of a human malaria-on-a-chip disease model for drug efficacy and off-target toxicity evaluation"],"prefix":"10.1038","volume":"13","author":[{"given":"Michael J.","family":"Rupar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor","family":"Sasserath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Comiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narasimhan","family":"Sriram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher W.","family":"McAleer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Hickman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,28]]},"reference":[{"issue":"Supplement_2","key":"35694_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0035-9203(90)90363-J","volume":"84","author":"World Health Organization","year":"1990","unstructured":"World Health Organization. Severe and complicated malaria. Trans. R. Soc. Trop. Med. Hyg. 84(Supplement_2), 1\u201365. https:\/\/doi.org\/10.1016\/0035-9203(90)90363-J (1990).","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"issue":"10130","key":"35694_CR2","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1016\/S0140-6736(18)30324-6","volume":"391","author":"EA Ashley","year":"2018","unstructured":"Ashley, E. A., Pyae Phyo, A. & Woodrow, C. J. Malaria. Lancet 391(10130), 1608\u20131621 (2018).","journal-title":"Lancet"},{"key":"35694_CR3","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1146\/annurev-pathmechdis-012419-032640","volume":"15","author":"CA Moxon","year":"2020","unstructured":"Moxon, C. A. et al. New insights into malaria pathogenesis. Annu. Rev. Pathol. 15, 315\u2013343 (2020).","journal-title":"Annu. Rev. Pathol."},{"key":"35694_CR4","doi-asserted-by":"publisher","first-page":"17050","DOI":"10.1038\/nrdp.2017.50","volume":"3","author":"MA Phillips","year":"2017","unstructured":"Phillips, M. A. et al. Malaria. Nat. Rev. Dis. Primers 3, 17050 (2017).","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"6872","key":"35694_CR5","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/415673a","volume":"415","author":"LH Miller","year":"2002","unstructured":"Miller, L. H. et al. The pathogenic basis of malaria. Nature 415(6872), 673\u2013679 (2002).","journal-title":"Nature"},{"issue":"6","key":"35694_CR6","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1128\/AAC.45.6.1847-1853.2001","volume":"45","author":"A Moreno","year":"2001","unstructured":"Moreno, A. et al. Human malaria in immunocompromised mice: New in vivo model for chemotherapy studies. Antimicrob. Agents Chemother 45(6), 1847\u20131853 (2001).","journal-title":"Antimicrob. Agents Chemother"},{"issue":"5","key":"35694_CR7","doi-asserted-by":"publisher","first-page":"e2252","DOI":"10.1371\/journal.pone.0002252","volume":"3","author":"I Angulo-Barturen","year":"2008","unstructured":"Angulo-Barturen, I. et al. A murine model of falciparum-malaria by in vivo selection of competent strains in non-myelodepleted mice engrafted with human erythrocytes. PLoS ONE 3(5), e2252 (2008).","journal-title":"PLoS ONE"},{"key":"35694_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.addr.2017.09.013","volume":"128","author":"ST Sanjay","year":"2018","unstructured":"Sanjay, S. T. et al. Recent advances of controlled drug delivery using microfluidic platforms. Adv. Drug Deliv. Rev. 128, 3\u201328 (2018).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"35694_CR9","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/978-3-030-36588-2_3","volume":"1230","author":"LA Low","year":"2020","unstructured":"Low, L. A. et al. Organs-on-a-chip. Adv. Exp. Med. Biol. 1230, 27\u201342 (2020).","journal-title":"Adv. Exp. Med. Biol."},{"issue":"1\u20132","key":"35694_CR10","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/0165-0270(95)00063-1","volume":"62","author":"AE Schaffner","year":"1995","unstructured":"Schaffner, A. E. et al. Investigation of the factors necessary for growth of hippocampal neurons in a defined system. J. Neurosci. Methods 62(1\u20132), 111\u2013119 (1995).","journal-title":"J. Neurosci. Methods"},{"issue":"25","key":"35694_CR11","doi-asserted-by":"publisher","first-page":"5643","DOI":"10.1016\/j.biomaterials.2004.01.020","volume":"25","author":"M Das","year":"2004","unstructured":"Das, M. et al. Long-term culture of embryonic rat cardiomyocytes on an organosilane surface in a serum-free medium. Biomaterials 25(25), 5643\u20135647 (2004).","journal-title":"Biomaterials"},{"issue":"3","key":"35694_CR12","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.tiv.2005.08.014","volume":"20","author":"A Natarajan","year":"2006","unstructured":"Natarajan, A. et al. Microelectrode array recordings of cardiac action potentials as a high throughput method to evaluate pesticide toxicity. Toxicol. In Vitro 20(3), 375\u2013381 (2006).","journal-title":"Toxicol. In Vitro"},{"key":"35694_CR13","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.biomaterials.2015.04.035","volume":"60","author":"M Stancescu","year":"2015","unstructured":"Stancescu, M. et al. A phenotypic in vitro model for the main determinants of human whole heart function. Biomaterials 60, 20\u201330 (2015).","journal-title":"Biomaterials"},{"issue":"2","key":"35694_CR14","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jneumeth.2010.04.030","volume":"190","author":"D Edwards","year":"2010","unstructured":"Edwards, D. et al. Addition of glutamate to serum-free culture promotes recovery of electrical activity in adult hippocampal neurons in vitro. J. Neurosci. Methods 190(2), 155\u2013163 (2010).","journal-title":"J. Neurosci. Methods"},{"issue":"2","key":"35694_CR15","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.neuroscience.2007.01.068","volume":"146","author":"M Das","year":"2007","unstructured":"Das, M. et al. Embryonic motoneuron-skeletal muscle co-culture in a defined system. Neuroscience 146(2), 481\u2013488 (2007).","journal-title":"Neuroscience"},{"issue":"6","key":"35694_CR16","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1089\/ten.tec.2010.0040","volume":"16","author":"X Guo","year":"2010","unstructured":"Guo, X. et al. Neuromuscular junction formation between human stem-cell-derived motoneurons and rat skeletal muscle in a defined system. Tissue Eng. Part C Methods 16(6), 1347\u20131355 (2010).","journal-title":"Tissue Eng. Part C Methods"},{"issue":"32","key":"35694_CR17","doi-asserted-by":"publisher","first-page":"8218","DOI":"10.1016\/j.biomaterials.2010.07.027","volume":"31","author":"JW Rumsey","year":"2010","unstructured":"Rumsey, J. W. et al. Tissue engineering the mechanosensory circuit of the stretch reflex arc: Sensory neuron innervation of intrafusal muscle fibers. Biomaterials 31(32), 8218\u20138227 (2010).","journal-title":"Biomaterials"},{"issue":"18","key":"35694_CR18","doi-asserted-by":"publisher","first-page":"4418","DOI":"10.1016\/j.biomaterials.2013.02.061","volume":"34","author":"X Guo","year":"2013","unstructured":"Guo, X. et al. Derivation of sensory neurons and neural crest stem cells from human neural progenitor hNP1. Biomaterials 34(18), 4418\u20134427 (2013).","journal-title":"Biomaterials"},{"issue":"7","key":"35694_CR19","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1038\/nprot.2007.229","volume":"2","author":"M Das","year":"2007","unstructured":"Das, M. et al. Differentiation of skeletal muscle and integration of myotubes with silicon microstructures using serum-free medium and a synthetic silane substrate. Nat. Protoc. 2(7), 1795\u20131801 (2007).","journal-title":"Nat. Protoc."},{"issue":"36","key":"35694_CR20","doi-asserted-by":"publisher","first-page":"9602","DOI":"10.1016\/j.biomaterials.2011.09.014","volume":"32","author":"X Guo","year":"2011","unstructured":"Guo, X. et al. Neuromuscular junction formation between human stem cell-derived motoneurons and human skeletal muscle in a defined system. Biomaterials 32(36), 9602\u20139611 (2011).","journal-title":"Biomaterials"},{"key":"35694_CR21","doi-asserted-by":"publisher","first-page":"20030","DOI":"10.1038\/srep20030","volume":"6","author":"C Oleaga","year":"2016","unstructured":"Oleaga, C. et al. Multi-organ toxicity demonstration in a functional human in vitro system composed of four organs. Sci. Rep. 6, 20030 (2016).","journal-title":"Sci. Rep."},{"issue":"8","key":"35694_CR22","doi-asserted-by":"publisher","first-page":"1805792","DOI":"10.1002\/adfm.201970049","volume":"29","author":"C Oleaga","year":"2019","unstructured":"Oleaga, C. et al. Long-term electrical and mechanical function monitoring of a human-on-a-chip system. Adv. Funct. Mater. 29(8), 1805792 (2019).","journal-title":"Adv. Funct. Mater."},{"issue":"3","key":"35694_CR23","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/S0035-9203(97)90110-3","volume":"91","author":"SL Cranmer","year":"1997","unstructured":"Cranmer, S. L. et al. An alternative to serum for cultivation of Plasmodium falciparum in vitro. Trans. R. Soc. Trop. Med. Hyg. 91(3), 363\u2013365 (1997).","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"issue":"2","key":"35694_CR24","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.exppara.2006.12.003","volume":"116","author":"K Srivastava","year":"2007","unstructured":"Srivastava, K. et al. In vitro cultivation of Plasmodium falciparum: Studies with modified medium supplemented with ALBUMAX II and various animal sera. Exp. Parasitol. 116(2), 171\u2013174 (2007).","journal-title":"Exp. Parasitol."},{"key":"35694_CR25","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s12936-015-0718-z","volume":"14","author":"J Reader","year":"2015","unstructured":"Reader, J. et al. Nowhere to hide: Interrogating different metabolic parameters of Plasmodium falciparum gametocytes in a transmission blocking drug discovery pipeline towards malaria elimination. Malar. J. 14, 213 (2015).","journal-title":"Malar. J."},{"issue":"8","key":"35694_CR26","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1177\/1087057107310638","volume":"12","author":"K Singh","year":"2007","unstructured":"Singh, K. et al. Growth, drug susceptibility, and gene expression profiling of Plasmodium falciparum cultured in medium supplemented with human serum or lipid-rich bovine serum albumin [corrected]. J. Biomol. Screen 12(8), 1109\u20131114 (2007).","journal-title":"J. Biomol. Screen"},{"issue":"3","key":"35694_CR27","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1111\/j.1462-5822.2011.01741.x","volume":"14","author":"HA Del Portillo","year":"2012","unstructured":"Del Portillo, H. A. et al. The role of the spleen in malaria. Cell Microbiol. 14(3), 343\u2013355 (2012).","journal-title":"Cell Microbiol."},{"issue":"11","key":"35694_CR28","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1056\/NEJM198709103171105","volume":"317","author":"S Looareesuwan","year":"1987","unstructured":"Looareesuwan, S. et al. Dynamic alteration in splenic function during acute falciparum malaria. N. Engl. J. Med. 317(11), 675\u2013679 (1987).","journal-title":"N. Engl. J. Med."},{"key":"35694_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0035-9203(90)90363-J","volume":"84","author":"Organization, W. H.","year":"1990","unstructured":"Organization, W. H. Severe and complicated malaria. Trans. R. Soc. Trop. Med. Hyg. 84, 1\u201365 (1990).","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"issue":"7","key":"35694_CR30","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1016\/j.biocel.2008.12.012","volume":"41","author":"ND Pasternak","year":"2009","unstructured":"Pasternak, N. D. & Dzikowski, R. PfEMP1: An antigen that plays a key role in the pathogenicity and immune evasion of the malaria parasite Plasmodium falciparum. Int. J. Biochem. Cell Biol. 41(7), 1463\u20131466 (2009).","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"6","key":"35694_CR31","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/S0020-7519(99)00049-1","volume":"29","author":"C Newbold","year":"1999","unstructured":"Newbold, C. et al. Cytoadherence, pathogenesis and the infected red cell surface in Plasmodium falciparum. Int. J. Parasitol. 29(6), 927\u2013937 (1999).","journal-title":"Int. J. Parasitol."},{"issue":"4","key":"35694_CR32","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.mib.2006.06.006","volume":"9","author":"SM Kraemer","year":"2006","unstructured":"Kraemer, S. M. & Smith, J. D. A family affair: Var genes, PfEMP1 binding, and malaria disease. Curr. Opin. Microbiol. 9(4), 374\u2013380 (2006).","journal-title":"Curr. Opin. Microbiol."},{"key":"35694_CR33","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/bs.apar.2015.02.004","volume":"88","author":"L Hviid","year":"2015","unstructured":"Hviid, L. & Jensen, A. T. PfEMP1\u2014a parasite protein family of key importance in Plasmodium falciparum malaria immunity and pathogenesis. Adv. Parasitol. 88, 51\u201384 (2015).","journal-title":"Adv. Parasitol."},{"issue":"3","key":"35694_CR34","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.chom.2017.02.009","volume":"21","author":"F Lennartz","year":"2017","unstructured":"Lennartz, F. et al. Structure-guided identification of a family of dual receptor-binding pfemp1 that is associated with cerebral malaria. Cell Host Microbe 21(3), 403\u2013414 (2017).","journal-title":"Cell Host Microbe"},{"issue":"4","key":"35694_CR35","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1093\/infdis\/jit419","volume":"209","author":"CA Moxon","year":"2014","unstructured":"Moxon, C. A. et al. Persistent endothelial activation and inflammation after Plasmodium falciparum infection in Malawian children. J. Infect. Dis. 209(4), 610\u2013615 (2014).","journal-title":"J. Infect. Dis."},{"issue":"6","key":"35694_CR36","doi-asserted-by":"publisher","first-page":"a025551","DOI":"10.1101\/cshperspect.a025551","volume":"7","author":"M Fried","year":"2017","unstructured":"Fried, M. & Duffy, P. E. Malaria during pregnancy. Cold Spring Harb Perspect Med 7(6), a025551 (2017).","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"3","key":"35694_CR37","doi-asserted-by":"publisher","first-page":"188","DOI":"10.2174\/157016310793180576","volume":"7","author":"J Sahi","year":"2010","unstructured":"Sahi, J., Grepper, S. & Smith, C. Hepatocytes as a tool in drug metabolism, transport and safety evaluations in drug discovery. Curr. Drug Discov. Technol. 7(3), 188\u2013198 (2010).","journal-title":"Curr. Drug Discov. Technol."},{"issue":"12","key":"35694_CR38","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.4155\/bio.12.133","volume":"4","author":"XJ Li","year":"2012","unstructured":"Li, X. J. et al. Microfluidic 3D cell culture: Potential application for tissue-based bioassays. Bioanalysis 4(12), 1509\u20131525 (2012).","journal-title":"Bioanalysis"},{"issue":"1","key":"35694_CR39","doi-asserted-by":"publisher","first-page":"9619","DOI":"10.1038\/s41598-019-45656-4","volume":"9","author":"CW McAleer","year":"2019","unstructured":"McAleer, C. W. et al. On the potential of in vitro organ-chip models to define temporal pharmacokinetic-pharmacodynamic relationships. Sci. Rep. 9(1), 9619 (2019).","journal-title":"Sci. Rep."},{"key":"35694_CR40","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1146\/annurev-bioeng-071910-124629","volume":"13","author":"MB Esch","year":"2011","unstructured":"Esch, M. B., King, T. L. & Shuler, M. L. The role of body-on-a-chip devices in drug and toxicity studies. Annu. Rev. Biomed. Eng. 13, 55\u201372 (2011).","journal-title":"Annu. Rev. Biomed. Eng."},{"issue":"4","key":"35694_CR41","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1039\/b917763a","volume":"10","author":"JH Sung","year":"2010","unstructured":"Sung, J. H., Kam, C. & Shuler, M. L. A microfluidic device for a pharmacokinetic-pharmacodynamic (PK-PD) model on a chip. Lab. Chip 10(4), 446\u2013455 (2010).","journal-title":"Lab. Chip"},{"key":"35694_CR42","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1126\/scitranslmed.aav1386","volume":"11","author":"CW McAleer","year":"2019","unstructured":"McAleer, C. W. et al. Multi-organ system for the evaluation of efficacy and off-target toxicity of anticancer therapeutics. Sci. Transl. Med. 11, 497 (2019).","journal-title":"Sci. Transl. Med."},{"issue":"4254","key":"35694_CR43","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1126\/science.781840","volume":"193","author":"W Trager","year":"1976","unstructured":"Trager, W. & Jensen, J. B. Human malaria parasites in continuous culture. Science 193(4254), 673\u2013675 (1976).","journal-title":"Science"},{"issue":"6","key":"35694_CR44","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nrd1416","volume":"3","author":"DA Fidock","year":"2004","unstructured":"Fidock, D. A. et al. Antimalarial drug discovery: Efficacy models for compound screening. Nat. Rev. Drug Discov. 3(6), 509\u2013520 (2004).","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"35694_CR45","doi-asserted-by":"publisher","first-page":"10925","DOI":"10.1038\/s41598-020-67817-6","volume":"10","author":"L Ciuffreda","year":"2020","unstructured":"Ciuffreda, L. et al. Estimation of parasite age and synchrony status in Plasmodium falciparum infections. Sci. Rep. 10(1), 10925 (2020).","journal-title":"Sci. Rep."},{"key":"35694_CR46","unstructured":"Organization, W.H. In Guidelines for the Treatment of Malaria (Geneva, 2015)."},{"key":"35694_CR47","unstructured":"Fitch, C. D. Involvement of heme in the antimalarial action of chloroquine. Trans. Am. Clin. Climatol. Assoc. 109, 97\u2013105; discussion 105\u20136 (1998)."},{"issue":"2\u20133","key":"35694_CR48","first-page":"265","volume":"55","author":"IW Sherman","year":"1977","unstructured":"Sherman, I. W. Amino acid metabolism and protein synthesis in malarial parasites. Bull. World Health Organ. 55(2\u20133), 265\u2013276 (1977).","journal-title":"Bull. World Health Organ."},{"issue":"8","key":"35694_CR49","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/0169-4758(92)90146-S","volume":"8","author":"DE Goldberg","year":"1992","unstructured":"Goldberg, D. E. & Slater, A. F. The pathway of hemoglobin degradation in malaria parasites. Parasitol. Today 8(8), 280\u2013283 (1992).","journal-title":"Parasitol. Today"},{"issue":"6519","key":"35694_CR50","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/374269a0","volume":"374","author":"A Dorn","year":"1995","unstructured":"Dorn, A. et al. Malarial haemozoin\/beta-haematin supports haem polymerization in the absence of protein. Nature 374(6519), 269\u2013271 (1995).","journal-title":"Nature"},{"issue":"16","key":"35694_CR51","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1016\/j.lfs.2003.10.003","volume":"74","author":"CD Fitch","year":"2004","unstructured":"Fitch, C. D. Ferriprotoporphyrin IX, phospholipids, and the antimalarial actions of quinoline drugs. Life Sci. 74(16), 1957\u20131972 (2004).","journal-title":"Life Sci."},{"issue":"1","key":"35694_CR52","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0163-7258(98)00012-6","volume":"79","author":"M Foley","year":"1998","unstructured":"Foley, M. & Tilley, L. Quinoline antimalarials: Mechanisms of action and resistance and prospects for new agents. Pharmacol. Ther. 79(1), 55\u201387 (1998).","journal-title":"Pharmacol. Ther."},{"issue":"10","key":"35694_CR53","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/S1471-4922(02)02373-5","volume":"18","author":"NJ White","year":"2002","unstructured":"White, N. J. The assessment of antimalarial drug efficacy. Trends Parasitol. 18(10), 458\u2013464 (2002).","journal-title":"Trends Parasitol."},{"issue":"11","key":"35694_CR54","doi-asserted-by":"publisher","first-page":"4271","DOI":"10.1128\/AAC.48.11.4271-4280.2004","volume":"48","author":"K Stepniewska","year":"2004","unstructured":"Stepniewska, K. et al. In vivo assessment of drug efficacy against Plasmodium falciparum malaria: Duration of follow-up. Antimicrob. Agents Chemother. 48(11), 4271\u20134280 (2004).","journal-title":"Antimicrob. Agents Chemother."},{"issue":"13","key":"35694_CR55","doi-asserted-by":"publisher","first-page":"2000323","DOI":"10.1002\/advs.202000323","volume":"7","author":"T Sasserath","year":"2020","unstructured":"Sasserath, T. et al. Differential monocyte actuation in a three-organ functional innate immune system-on-a-chip. Adv. Sci. (Weinh) 7(13), 2000323 (2020).","journal-title":"Adv. Sci. (Weinh)"},{"key":"35694_CR56","volume-title":"Methods in Molecular Medicine","author":"G Pasvol","year":"2002","unstructured":"Pasvol, G. Malaria methods and protocols. In Methods in Molecular Medicine Vol. 72 (ed. Doolan, D. L.) (Humana Press, Totowa, NJ, 2002)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-35694-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-35694-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-35694-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T02:13:40Z","timestamp":1688004820000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-35694-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,28]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["35694"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-35694-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,28]]},"assertion":[{"value":"29 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors confirm that competing financial interests exist but the financial support for this research did not influence its outcome. The only author with competing interest is J.J.H. who has ownership interest and is Chief Scientist and member of the Board of Directors in a company that may benefit financially as a result of the outcomes of the research work reported in this publication. All other authors declare that they do not have any competing interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10509"}}